Simplex Trading
OMIC

Simplex Trading’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Simplex Trading’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-710
Closed -$8K – 10123
2023
Q3 		$8K Hold
710
– – ﹤0.01% 7380
2023
Q2 		$17K Hold
710
– – ﹤0.01% 6948
2023
Q1 		$25K Buy
+710
New +$43.5K ﹤0.01% 6697

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Simplex Trading's OMIC Position: Q1 2024 in Review

Simplex Trading sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2024, closing a stake of 17 shares.

Simplex Trading first reported a position in OMIC in Q3 2022 and held it in 6 quarters. The position peaked at $2K in Q4 2022. 42 funds tracked by Wall St. Rank hold OMIC as of Q1 2024.

  • Simplex Trading reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 17 Singular Genomics Systems, Inc. Common Stock shares in Q1 2024.
  • Simplex Trading first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Simplex Trading's Singular Genomics Systems, Inc. Common Stock position peaked at $2K in Q4 2022.
  • 42 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.